AI-Designed Drug for IPF Gets Name, Fares Well in Early Trials

Retrieved on: 2025-04-07 21:36:43

Tags for this article:

Click the tags to see associated articles and topics

AI-Designed Drug for IPF Gets Name, Fares Well in Early Trials. View article details on hiswai:

Excerpt

An AI-designed drug for idiopathic pulmonary fibrosis (IPF) created by Boston-based biotech firm Insilico Medicine, has been granted an official ...

Article found on: www.managedhealthcareexecutive.com